Elsevier Appoints New Managing Director for Global Clinical Reference Group
Jim Donohue to lead development of ClinicalKey, world’s first clinical insight engine
Philadelphia, PA, April 25, 2012 – Elsevier, a world-leading provider of scientific, technical and medical information products and services, has appointed Jim Donohue as Managing Director of the Global Clinical Reference group in Elsevier Health Sciences. In this new role, Donohue will report to Michael Hansen, CEO of Elsevier Health Sciences.
One of Donohue’s first responsibilities is the commercial launch in April 2012 of Elsevier’s ClinicalKey, the world’s first clinical insight engine. ClinicalKey provides relevant, fast, trusted and comprehensive clinical answers for clinicians.
“Jim brings much experience and valuable knowledge to his new role at Elsevier Health Science,” said Michael Hansen, CEO of Elsevier Health Sciences. “Healthcare is increasingly content and data-driven, and we are continuously looking for new and better ways to put our world-leading medical reference content into the hands of clinicians around the globe. Jim and his team will be spearheading those efforts.”
Jim Donohue started at Elsevier in 2006 as Managing Director for Science & Technology books and then worked as the SVP/General Manager of MD Consult. Prior to Elsevier, Donohue served as the Senior Vice President of Sales and Marketing for Augsburg Fortress, and prior to that he founded and served as CEO of NetDoctor, the U.K.’s leading internet health website and one of the fifth most visible websites in the U.K. at the time. Donohue has also held vice president positions for EMEA at Times Mirror International Publishers, and was vice president for marketing at Harper Collins.
Jim is based in Philadelphia. He has a B.A. in Political Science and Rhetoric from the University of Arizona and an M.A. in Rhetoric and Public Address from the University of Iowa.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group plc, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group plc is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.